Cedrus LLC Zoetis Inc. Transaction History

Cedrus LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 26, 2024	BUY	$151.44 - $200.09 $162,798 - $215,096	1,075 New	1,075 $212 Million
Q3 2023 Jan 24, 2024	SELL	$167.14 - $192.77 $223,633 - $257,926	-1,338 Closed	0 $0
Q2 2023 Jan 24, 2024	SELL	$160.94 - $186.23 $12,553 - $14,525	-78 Reduced 5.51%	1,338 $230 Million
Q1 2023 Jan 24, 2024	SELL	$145.48 - $175.02 $3,927 - $4,725	-27 Reduced 1.87%	1,416 $236 Million
Q4 2022 Jan 19, 2024	BUY	$131.14 - $157.47 $11,409 - $13,699	87 Added 6.42%	1,443 $211 Million
Q3 2022 Jan 19, 2024	BUY	$148.29 - $182.55 $1,334 - $1,642	9 Added 0.67%	1,356 $201 Million
Q2 2022 Jan 19, 2024	BUY	$155.97 - $200.09 $5,147 - $6,602	33 Added 2.51%	1,347 $232 Million
Q1 2022 Jan 19, 2024	SELL	$181.39 - $234.03 $51,514 - $66,464	-284 Reduced 17.77%	1,314 $248 Million
Q4 2021 Jan 19, 2024	BUY	$193.69 - $247.03 $309,516 - $394,753	1,598 New	1,598 $390 Million

1,957

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Cedrus LLC, based on Form 13F filings with the SEC.

Stay updated on Cedrus LLC with notifications on news.